Marlies Blom

562 total citations
5 papers, 400 citations indexed

About

Marlies Blom is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Marlies Blom has authored 5 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Rheumatology, 3 papers in Radiology, Nuclear Medicine and Imaging and 1 paper in Surgery. Recurrent topics in Marlies Blom's work include Rheumatoid Arthritis Research and Therapies (4 papers), Systemic Lupus Erythematosus Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Marlies Blom is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (4 papers), Systemic Lupus Erythematosus Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Marlies Blom collaborates with scholars based in Netherlands, United States and Belgium. Marlies Blom's co-authors include M. A. van Leeuwen, Cees G. M. Kallenberg, Albert Holvast, Sander van Assen, Alexandre E. Voskuyl, Johanna Westra, Aalzen de Haan, C. A. Benne, Marc Bijl and Marcel D. Posthumus and has published in prestigious journals such as Obstetrics and Gynecology, Journal of Autoimmunity and The Journal of Rheumatology.

In The Last Decade

Marlies Blom

5 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marlies Blom Netherlands 5 205 136 94 72 67 5 400
Valentina Germano Italy 14 261 1.3× 147 1.1× 43 0.5× 63 0.9× 40 0.6× 18 492
Nashla Barroso United States 4 107 0.5× 109 0.8× 43 0.5× 48 0.7× 34 0.5× 7 324
Georgina Salvador Spain 13 348 1.7× 109 0.8× 39 0.4× 140 1.9× 22 0.3× 20 501
Ewa Więsik–Szewczyk Poland 10 119 0.6× 185 1.4× 46 0.5× 39 0.5× 38 0.6× 56 353
Adolfo Camargo‐Coronel Mexico 9 329 1.6× 149 1.1× 53 0.6× 43 0.6× 23 0.3× 18 428
Alessandra Zaccardelli United States 15 282 1.4× 51 0.4× 32 0.3× 57 0.8× 88 1.3× 28 581
Carmen Hidalgo Spain 7 135 0.7× 113 0.8× 53 0.6× 17 0.2× 34 0.5× 18 301
Ruth Fernandez‐Ruiz United States 11 295 1.4× 251 1.8× 50 0.5× 24 0.3× 106 1.6× 22 545
Naoshi Nishina Japan 11 242 1.2× 155 1.1× 26 0.3× 86 1.2× 32 0.5× 22 479
A. Gibofsky United States 2 206 1.0× 93 0.7× 27 0.3× 81 1.1× 29 0.4× 3 320

Countries citing papers authored by Marlies Blom

Since Specialization
Citations

This map shows the geographic impact of Marlies Blom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marlies Blom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marlies Blom more than expected).

Fields of papers citing papers by Marlies Blom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marlies Blom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marlies Blom. The network helps show where Marlies Blom may publish in the future.

Co-authorship network of co-authors of Marlies Blom

This figure shows the co-authorship network connecting the top 25 collaborators of Marlies Blom. A scholar is included among the top collaborators of Marlies Blom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marlies Blom. Marlies Blom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Blom, Marlies, Wietske Kievit, A. Rogier T. Donders, et al.. (2011). Effectiveness of a Third Tumor Necrosis Factor-α-blocking Agent Compared with Rituximab After Failure of 2 TNF-blocking Agents in Rheumatoid Arthritis. The Journal of Rheumatology. 38(11). 2355–2361. 22 indexed citations
2.
Somers, Klaartje, Piet Geusens, Dirk Elewaut, et al.. (2010). Novel autoantibody markers for early and seronegative rheumatoid arthritis. Journal of Autoimmunity. 36(1). 33–46. 56 indexed citations
3.
Assen, Sander van, Albert Holvast, C. A. Benne, et al.. (2009). Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab. Arthritis & Rheumatism. 62(1). 75–81. 259 indexed citations
4.
Blom, Marlies, Wietske Kievit, Jaap Fransen, et al.. (2009). The Reason for Discontinuation of the First Tumor Necrosis Factor (TNF) Blocking Agent Does Not Influence the Effect of a Second TNF Blocking Agent in Patients with Rheumatoid Arthritis. The Journal of Rheumatology. 36(10). 2171–2177. 40 indexed citations
5.
Traas, M A F, et al.. (2006). Surgical Treatment for the Vulvar Vestibulitis Syndrome. Obstetrics and Gynecology. 107(2, Part 1). 256–262. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026